This $12,784,460 Cooperative Agreement, awarded by the Department of Health and Human Services Centers for Disease Control and Prevention under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939), supports a comprehensive HIV prevention and surveillance program in New York. The primary objectives are to increase knowledge of HIV status, reduce transmission, prevent new infections, improve linkage to care and viral suppression, and maintain elimination of...
The federal Cooperative Agreement award NU38PS004654, titled "PREVENTION POLICY MODELING LAB", was awarded by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The $1,830,400.00 grant, with a performance period from September 30, 2024 to September 29, 2029, supports the development and maintenance of simulation and mathematical models for diseases such as tuberculosis, sexually transmitted diseases...
This $4,989,475 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) is intended to build the capacity of healthcare organizations, community-based organizations, and state/local health departments to implement high-impact HIV prevention initiatives. The award, with a period of performance from August 2024 to March 2029, will provide technical assistance, training,...
This Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834), will deliver a range of services to build the capacity of healthcare organizations, community-based organizations, and state/local health departments to implement high-impact HIV prevention initiatives. The $4,989,475 award, with a performance period from August 2024 to March 2029, will fund technical...
This $1,376,850 federal Project Grant award, issued on August 9, 2024 by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), is supporting research to develop interventions to protect HIV-exposed uninfected (HEU) infants against severe infections. The key goals are to: Define the immunogenomic and metabolomic profiles that explain the increased immune dysfunction and vulnerability to infections in...
The Centers for Disease Control and Prevention (CDC) awarded a five-year, $2,745,600 Cooperative Agreement to Emory University under the HIV Prevention Activities Health Department Based program (CFDA 93.940) to support comprehensive HIV prevention, surveillance, and treatment efforts. The funding will enable Emory University, in collaboration with the University of Washington, Johns Hopkins University, and Oregon Health & Science University, to conduct research and modeling to improve...
This $7,013,957 Cooperative Agreement award from the Department of Health and Human Services' Centers for Disease Control and Prevention (CFDA 93.067 - Global AIDS) supports the "Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE)" program. The agreement, running from September 30, 2024 to September 29, 2028, is with the Regents of the University of California, San Francisco (UCSF) to strengthen HIV prevention,...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) provides $27,841,482 in funding to the Los Angeles County Department of Public Health (DPH) Division of HIV and STD Programs. The award supports comprehensive HIV prevention, surveillance, and treatment efforts in Los Angeles County, which has a significant HIV epidemic with over 59,300 persons living with diagnosed HIV,...
This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $5,900,000.00 in funding to the National Health Laboratory Service (NHLS), a non-profit organization based in South Africa. The award supports NHLS's work in infectious disease surveillance, including activities such as HIV drug resistance monitoring, influenza and COVID-19 research, and pandemic preparedness. Key projects include establishing...
This $4,698,013 Cooperative Agreement awarded by the National Center for HIV/AIDS, a division of the U.S. Department of Health and Human Services, is funded under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939). The agreement aims to increase knowledge of HIV status, reduce HIV transmission, prevent new infections, improve linkage to care, increase viral suppression, and maintain elimination of perinatal HIV transmission in Minnesota. The Minnesota...